OpenVSafe by OpenVAERS
Search V-safe

E22-30436-64490

2 vaccinations 5 coded responses 18 check-ins 5 free-text entries 5 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
921 / CA
Registered
2020-12-22
Relationship
Self
Race
Multiracial
Ethnicity
N/A

Timeline

  1. 2020-12-22
    Registered in v-safe
  2. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  4. 2020-12-23
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  5. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Itching · Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  6. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · Headache, Rash, not including the immediate area around the injection site
    Adult check-in
  7. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection site
    Adult check-in
  8. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection site
    Adult check-in
  9. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection site
    Adult check-in
  10. 2020-12-30
    Health check-in — day 7, dose 1
    Feeling: Fair · Site: Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  11. 2021-01-05
    Survey response — day 14, dose 1
    MedDRA: Rash — Feeling: Fair
    Free text: Rash on back shoulders
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-12
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-12
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  14. 2021-01-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Myalgia — Feeling: Good · Site: Pain · Muscle or body aches · Be unable to do your normal daily activities
    Free text: Injection arm muscle hurts
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-13
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  16. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  18. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  19. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  20. 2021-01-19
    Health check-in — day 7, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  21. 2021-04-13
    Survey response — 3 months, dose 2
    MedDRA: Fatigue, Migraine, Nausea — Feeling: Poor · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Nauseousness and tired. Migraines
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-04-13
    Report sent to call center — 3 months, dose 2
    Be unable to work · Get care from a doctor or other healthcare professional
    1 call case(s)
  23. 2021-06-08
  24. 2021-07-15
    Survey response — 6 months, dose 2
    MedDRA: Anxiety, Atrial fibrillation, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: A.fib, anxiety and vomiting.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  25. 2021-07-15
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  26. 2021-07-26
  27. 2022-01-12
    Survey response — 12 months, dose 2
    MedDRA: Arrhythmia, Atrial fibrillation, COVID-19, Cardiac ablation — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Atrial Fibrillation and needed a cardiac ablasion for rapid heart rythem. Covid positive on 12302021 still recovering.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-01-12
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  29. 2022-01-17

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-12Pfizer-BioNTech

Call center

5 call center cases

3 unsuccessful · 2 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — day 14, dose 1

2021-01-05

Symptoms: Rash on back shoulders

Release 1 — days 1–6 daily, dose 2

2021-01-13

Systemic reaction (other): Injection arm muscle hurts

Release 7 — 3 months, dose 2

2021-04-13

Symptoms: Nauseousness and tired. Migraines

Release 9 — 6 months, dose 2

2021-07-15

Symptoms: A.fib, anxiety and vomiting.

Release 10 — 12 months, dose 2

2022-01-12

Symptoms: Atrial Fibrillation and needed a cardiac ablasion for rapid heart rythem. Covid positive on 12302021 still recovering.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnxiety ✓ · ✓
SDArrhythmia · · ✓
SDAtrial fibrillation ✓ · ✓
SDCardiac ablation · · ✓
SDCOVID-19 · · ✓
SDFatigue ✓ ✓ ✓
SDMigraine ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDRash ✓ ✓ ✓
SDVomiting ✓ · ✓
SROInjection site pain ○ ○ ○
SROMyalgia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release